These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 13434455)

  • 1. [Reactions in chronic schizophrenia to polyvalent antiencephalitic serum used for therapeutic purposes].
    RAVKIN IG; ALEKSANDROVA AP; LANDO LI; RODIN IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1957; 57(1):87-94. PubMed ID: 13434455
    [No Abstract]   [Full Text] [Related]  

  • 2. EEG changes associated with intensive promazine therapy.
    WINFIELD DL; AIVAZIAN GH
    Am Pract Dig Treat; 1959 Jul; 10(7):1182-8. PubMed ID: 13661551
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia.
    Coelho FM; Reis HJ; Nicolato R; Romano-Silva MA; Teixeira MM; Bauer ME; Teixeira AL
    Neuroimmunomodulation; 2008; 15(2):140-4. PubMed ID: 18679053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-NMDA receptor encephalitis: a video case report.
    Labate A; Irani SR; Vincent A; Gambardella A; Piane EL; Cianci V; Aguglia U
    Epileptic Disord; 2009 Sep; 11(3):267-9. PubMed ID: 19713171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamics of bioelectrical activity of the brain in schizophrenia related to insulin therapy].
    CHUDNOVSKII VS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1958; 58(9):1079-89. PubMed ID: 13616648
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychophysiological studies on schizophrenic patients; the effect of cortisone administration and with-drawal upon behavior, serum 17-hydroxycorticosteroids, critical flicker frequency and electroencephalographic tracings.
    CLARK LD; EIK-NES K
    J Nerv Ment Dis; 1956 Nov; 124(5):473-7. PubMed ID: 13463601
    [No Abstract]   [Full Text] [Related]  

  • 7. [Further contributions to study of the therapeutic effects of combined reserpine and orphenadrine in massive doses in chronic schizophrenia].
    BALLERINI A; GERMANO G
    Rass Studi Psichiatr; 1961; 50():215-20. PubMed ID: 13686389
    [No Abstract]   [Full Text] [Related]  

  • 8. Serial electroencephalographic changes due to electrotherapy.
    KLOTZ M
    Dis Nerv Syst; 1955 Apr; 16(4):120-1. PubMed ID: 14365588
    [No Abstract]   [Full Text] [Related]  

  • 9. [The electroencephalogram (EEG) in insulin shock therapy].
    SOLIS J; VARA R
    Nervenarzt; 1957 Aug; 28(8):373-5. PubMed ID: 13517419
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electroencephalographic findings in Fiamberti's acetylcholine therapy].
    ALBERTI G
    Rass Studi Psichiatr; 1961; 50():427-39. PubMed ID: 13682130
    [No Abstract]   [Full Text] [Related]  

  • 11. Ego-pathology, body experience, and body psychotherapy in chronic schizophrenia.
    Röhricht F; Papadopoulos N; Suzuki I; Priebe S
    Psychol Psychother; 2009 Mar; 82(Pt 1):19-30. PubMed ID: 18789189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced N-acetylaspartate in the basal ganglia of a patient with anti-NMDA receptor encephalitis.
    Kataoka H; Dalmau J; Taoka T; Ueno S
    Mov Disord; 2009 Apr; 24(5):784-6. PubMed ID: 19217070
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mycoplasma pneumoniae encephalitis in immunocompetent child].
    Palumbo E; Malorgio C; Nasca G; Siani A; Branchi M; Bonora G
    Recenti Prog Med; 2008 Jun; 99(6):306-8. PubMed ID: 18710062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The place of cognitive-behavioral therapy in schizophrenia: a review of the literature].
    Zaarour Z
    Rev Med Brux; 2008; 29(2):95-101. PubMed ID: 18561837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial results in the treatment of chronic mental disorders with perphenazine (Trilafon). Therapeutic and psychopathological research].
    GREGORETTI L
    Riv Sper Freniatr Med Leg Alien Ment; 1960 Sep; 84():689-704. PubMed ID: 13708414
    [No Abstract]   [Full Text] [Related]  

  • 16. First-episode schizophrenia. A window of opportunity for optimizing care and outcomes.
    Buckley PE; Evans D
    Postgrad Med; 2006 Sep; Spec No():5-19. PubMed ID: 17128657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evaluation and management of patients with first-episode schizophrenia: a selective, clinical review of diagnosis, treatment, and prognosis.
    Freudenreich O; Holt DJ; Cather C; Goff DC
    Harv Rev Psychiatry; 2007; 15(5):189-211. PubMed ID: 17924256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onset of schizophrenia at age 100.
    Cervantes AN; Rabins PV; Slavney PR
    Psychosomatics; 2006; 47(4):356-9. PubMed ID: 16844897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC
    World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of active therapy on verbal reactions in schizophrenia according to verbal experiment].
    TRAUGOTT NN
    Tr Inst Fiziol Im I P Pavlova; 1952; 1():436-53. PubMed ID: 13187661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.